State Street Corp Processa Pharmaceuticals, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$1.68 - $3.55 $2,184 - $4,615
1,300 Added 3.13%
42,786 $120,000
Q3 2021

Nov 15, 2021
BUY
$5.28 - $8.61 $131,398 - $214,268
24,886 Added 149.92%
41,486 $356,000
Q2 2021

Aug 16, 2021
BUY
$6.15 - $10.95 $102,090 - $181,770
16,600 New
16,600 $136,000

About Processa Pharmaceuticals, Inc.

PCSA Quotes by TradingView
  • Ticker PCSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,856,200
  • Market Cap $16.2M
  • Description
  • Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...
More about PCSA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email